Vodafone and UK-based pharmaceutical company AstraZeneca have announced a global partnership that’ll see them using mobile health services to help patients with cardiovascular conditions.
The collaboration will work in partnership with healthcare professionals, who’ll enable patients to use mobile and internet-based mHealth services during their treatment.